Phase 2 Neuroendocrine Tumors trials recruiting now

All Neuroendocrine Tumors trials, every phase

Other phases for Neuroendocrine Tumors

Phase 2 Neuroendocrine Tumors trials

• Administration of Autologous T-Cells Genetically Engineered to Express T-Cell Receptors Reactive Against Neoantigens in People With Metastatic Cancer
  NCT03412877 · Phase: Phase 2 · Ages: 18 Years to 72 Years · Sex: All (male and female) · 2 locations
• Agnostic Therapy in Rare Solid Tumors
  NCT06638931 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 8 locations
• Atezolizumab Plus Tivozanib in Immunologically Cold Tumor Types
  NCT05000294 · Phase: Phase 1, Phase 2 · Ages: 18 Years to 99 Years · Sex: All (male and female) · 1 location
• Cessation of Somatostatin Analogues After PRRT in Mid, Hind-Gut and Pancreatic Neuroendocrine Tumours
  NCT06345079 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 12 locations
• Everolimus 5 mg vs 10 mg/Daily for Patients With Neuroendocrine Tumors
  NCT06472388 · Phase: Phase 2 · Ages: 16 Years and older · Sex: All (male and female) · 2 locations
• Lu-177-DOTATATE (Lutathera) in Therapy of Inoperable Pheochromocytoma/ Paraganglioma
  NCT03206060 · Phase: Phase 2 · Ages: 18 Years to 100 Years · Sex: All (male and female) · 1 location
• Natural History and Management of Von Hippel-Lindau (VHL) Associated Pancreatic Neuroendocrine Tumors
  NCT04074135 · Phase: Phase 2 · Ages: 12 Years and older · Sex: All (male and female) · 1 location

Common questions

What does Phase 2 mean?

See how clinical trials work.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.